Sirio Pharma Co

Sirio Pharma Co Current Liabilities

The Current Liabilities of Sirio Pharma Co (300791.SZ) as of Nov 5, 2026 is 442.70 M CNY. In the previous year, Current Liabilities was 1.02 B CNY — a change of -56.69% (lower).

Current Liabilities

442.70 MCNY

YoY

-56.69%

Last updated:

Current Liabilities of Sirio Pharma Co is 2025 442.70 M CNY. Current Liabilities of Sirio Pharma Co was 2024 1.02 B CNY. It decreases by -56.69% lower compared to the previous year.

The Sirio Pharma Co Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2018
680.51 M CNY
Jan 1, 2019
293.62 M CNY
Jan 1, 2020
318.52 M CNY
Jan 1, 2021
338.77 M CNY
Jan 1, 2022
489.73 M CNY
Jan 1, 2023
978.82 M CNY
Jan 1, 2024
1.02 B CNY
Jan 1, 2025
442.70 M CNY
The Sirio Pharma Co Current Liabilities history
YEARCurrent LiabilitiesYoY
442.70 MCNY-56.69%
1.02 BCNY+4.42%
978.82 MCNY+99.87%
489.73 MCNY+44.56%
338.77 MCNY+6.36%
318.52 MCNY+8.48%
293.62 MCNY-56.85%
680.51 MCNY+50.20%
453.06 MCNY-36.80%
716.88 MCNY+102.06%
354.78 MCNY-3.31%
366.93 MCNY+42.31%
257.83 MCNY+14.39%
225.41 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Sirio Pharma Co Stock analysis

What does Sirio Pharma Co do? Sirio Pharma Co Ltd is a company based in Shantou, China, operating within the Consumer Staples sector and the Consumer products industry. The company went public on the Shenzhen Stock Exchange on September 25, 2019, with the ticker symbol 300791.SZ and ISIN CNE100003NB0. It employs 2,193 full-time staff and is engaged in the manufacturing of dietary supplement products. Sirio Pharma's product range includes soft capsules, tablets, powders, soft candy, hard capsules, and oral liquids. The company markets its products under the brand name WEWOW nutritional health food, distributing them both domestically within China and internationally. The company's official website is https://www.siriopharma.com/. Sirio Pharma focuses on the production and distribution of dietary supplements, targeting health-conscious consumers through its branded offerings. The firm's operations are centered in Shantou, Guangdong, and it serves markets in China and abroad. The company's primary business activities involve the development, manufacturing, and sale of dietary supplements, with a presence in both local and international markets. Sirio Pharma does not disclose specific details about its revenue, market share, or additional product lines beyond those mentioned. Sirio Pharma Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sirio Pharma Co stock

Current Liabilities of Sirio Pharma Co is 442.70 M CNY in 2025.

Current Liabilities of Sirio Pharma Co changed from 1.02 B CNY to 442.70 M CNY, representing a -56.69% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Sirio Pharma Co since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Sirio Pharma Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Sirio Pharma Co

All Key Metrics — Sirio Pharma Co